Collectively, our findings indicate that targeting TRIM28 may exert complex effects on tumor–immune interactions through modulation of key checkpoint molecules, underscoring the need for further mechanistic studies to elucidate the role of TRIM28 in immune escape within colorectal cancer. Here, TRIM28 is linked to neoplasm.